Financial News

Document Date Document Link
08/14/2018 BASi Reports Third Quarter Results with Revenue Gains
08/08/2018 Bioanalytical Systems to Release Third Quarter Fiscal 2018 Results on Tuesday, August 14, 2018
05/15/2018 BASi Reports Second Quarter Results
05/10/2018 Bioanalytical Systems to Release Second Quarter Fiscal 2018 Results on Tuesday, May 15, 2018
02/13/2018 BASi Reports First Quarter Results
02/08/2018 Bioanalytical Systems to Release First Quarter Fiscal 2018 Results on Tuesday, February 13, 2018
Document Date Document Link
12/19/2017 BASi Continues Profitability Improvement To Close out Fiscal 2017
12/15/2017 Bioanalytical Systems to Release Fourth Quarter and Full Year Fiscal 2017 Results on Tuesday, December 19, 2017
08/14/2017 BASi Reports Continued Profitability Improvement in Third Quarter
08/08/2017 Bioanalytical Systems to Release Third Quarter Fiscal 2017 Results on Monday, August 14, 2017
05/15/2017 BASi Reports Q2 2017 Results
02/14/2017 BASi Reports First Quarter Results
02/13/2017 Bioanalytical Systems to Release First Quarter Fiscal 2017 Results on Tuesday, February 14, 2017
Document Date Document Link
12/22/2016 BASi Reports Fiscal 2016 Full Year and Fourth Quarter Results
08/11/2016 BASi Reports Third Quarter Results
05/12/2016 BASi Reports Second Quarter Results
02/16/2016 BASi Reports First Quarter Results
Document Date Document Link
12/17/2015 BASi Reports Fiscal 2015 Full Year and Fourth Quarter Results
08/13/2015 BASi Reports Third Quarter Net Income of $0.16 per Share
05/14/2015 BASi Reports Second Quarter Results
02/12/2015 BASi Reports First Quarter Results
Document Date Document Link
12/22/2014 BASi Reports Fourth Quarter and Full Year 2014 Results
08/14/2014 BASi Reports Third Quarter Results
05/15/2014 BASi Reports Second Quarter Results
02/12/2014 BASi Reports First Quarter Results
Document Date Document Link
12/24/2013 BASi Reports Profitable 4th Quarter and Fiscal 2013
10/18/2013 BASi Reports Profitable Third Quarter
10/11/2013 BASi Files Amended Form 10-K and 10-Q with the SEC
08/21/2013 BASi Files Form 8K Notice of Non-Compliance with a Continued Listing Rule Non-Reliance on Previously Issued Financial Statements
08/14/2013 BASi Files Form 12b-25, Postpones Third Quarter Earnings Release and Conference Call
08/07/2013 Bioanalytical Systems to Release Third Quarter Results Wednesday, August 14, 2013; Conferece Call & Webcast Set for 11:00 a.m. EDT
05/15/2013 Bioanalytical Systems Reports Second Quarter Results
02/14/2013 BASi Reports First Quarter Net Income of $0.02 Per Share Versus A Prior Year First Quarter Net Loss of $0.21 Per Share

Corporate News

Document Date Document Link
07/09/2018 BASi Announces Appointment of John E. Sagartz to Board of Directors
07/02/2018 Seventh Wave Laboratories Combine Operations to Provide Broader Solutions and Greater Scientific Expertise to Clients
04/30/2018 James Bourdage to Retire as BASi VP of Bioanalytical Operations; Michael Baim Named as Successor
04/04/2018 BASi and Phlebotics Form Strategic Alliance; Continuing a Commitment to Automated Blood Sampling
03/27/2018 Bolstering Preclinical PK/PD Operations: BASi Hires Karen L. Rogers, DVM, DACLAM, CPIA as Attending Veterinarian
Document Date Document Link
12/12/2017 BASi Announces Enhanced Bioequivalence Capabilities
11/13/2017 Steady Growth Spurs Plans for BASi Expansion of GLP Toxicology Facility in Indiana
10/03/2017 Gaining Momentum: BASi Adds Candace Rohde-Johnson as Director of In Vivo Products and Services
09/19/2017 BASi Strengthens Preclinical PK/PD Leadership With the Hiring of James E. Burleigh as Director of Operations, Preclinical PK/PD
09/06/2017 BASi and JOANNEUM RESEARCH Enter Into Collaboration to Commercialize Open Flow Microperfusion Technology
08/28/2017 BASi Announces New Universal Caging System for Automated Sampling With Focus on Researcher-Friendly Design
08/03/2017 BASi Announces Election of R. Matthew Neff to the Board of Directors
07/31/2017 BASi Signs Reseller Agreement With LABEX of MA for Refurbished Culex® Automated Blood Sampling Systems
06/27/2017 BASi Completes Refinancing of Senior Secured Credit Facilities
06/20/2017 BASi Names Dr. Gregory C. Davis to Board of Directors
06/07/2017 BASi Announces Validated 'SEND' Capabilities and Compliance With FDA's Standard for Exchange of Nonclinical Data
05/01/2017 BASi Announces Appointment of Dr. Peter T. Kissinger as Scientific Advisor
03/08/2017 BASi Names Philip Downing Senior Vice President of Preclinical Services
Document Date Document Link
12/21/2016 BASi Names Alan Loch Director of Business Development
08/25/2016 BASi Launches Embrace Automation Grant Program with Culex NxT™ Automated Blood Sampling System
07/27/2016 BASi Expands Electrochemical Offerings by Partnering with PalmSens BV
05/11/2016 BASi Announces Appointment of New Chief Financial Officer
04/14/2016 BASi Launches New Website and E-Catalogue
03/29/2016 BASi Introduces the Next Generation of Electrochemical Analyzer With the Release of the Epsilon EClipse™
02/04/2016 BASi Awards Raturn® Systems for Optogenetic Research
Document Date Document Link
12/14/2015 BASi Names Wendy Perrow to Board of Directors
07/14/2015 BASi Announces Enhancements to the Company's Laboratory Information Management System (LIMS)
03/17/2015 BASi Names Philip A. Downing Vice President of Preclinical Services
02/12/2015 BASi Expands Scientific Expertise with the Hiring of Srini Jayaraman, Ph.D., Principal Investigator Discovery and Braden M. Kemmerling, D.V.M., Attending Veterinarian for Preclinical Services
Document Date Document Link
12/02/2014 BASi’s Culex® L Large Animal Sampling System Combines an Ideal Model with an Ideal Tool for Improved Drug Development Research
06/12/2014 BASi Names Jeffrey Potrzebowski CFO and James Bourdage VP Bioanalytical Operations
05/30/2014 BASi Hosts In Vivo Drug Discovery Workshop at UCLA
Document Date Document Link
10/16/2013 BASi Signs Preferred Provider Agreement with G1 Therapeutics
05/02/2013 BASi Launches Innovative Glucose Monitoring Project with Pinnacle Technology
Document Date Document Link
12/18/2012 BASi to Release Fourth Quarter & Fiscal 2012 Results Thursday, December 27, 2012; Conference Call & Webcast Set For 11:00 a.m. EDT